Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$51.52
-1.8%		$40.10
$25.36
▼
$53.50
$2.67B1.26706,606 shs714,123 shs
AxoGen, Inc. stock logo
AXGN
AxoGen
$48.28
+2.5%		$45.21
$15.27
▼
$52.91
$2.53B1.16841,648 shs550,066 shs
SiBone stock logo
SIBN
SiBone
$18.50
-0.8%		$18.12
$11.48
▼
$21.89
$826.67M0.7510,145 shs389,529 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$89.98
+3.4%		$80.14
$60.10
▼
$156.00
$3.11B1.9698,421 shs542,597 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-1.79%+6.14%+30.96%+90.11%+48.17%
AxoGen, Inc. stock logo
AXGN
AxoGen
+2.51%-6.20%+6.77%+12.80%+209.29%
SiBone stock logo
SIBN
SiBone
-0.75%-3.70%+2.55%+22.35%+14.06%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+3.45%+1.75%+17.64%+29.60%-15.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$51.52
-1.8%		$40.10
$25.36
▼
$53.50
$2.67B1.26706,606 shs714,123 shs
AxoGen, Inc. stock logo
AXGN
AxoGen
$48.28
+2.5%		$45.21
$15.27
▼
$52.91
$2.53B1.16841,648 shs550,066 shs
SiBone stock logo
SIBN
SiBone
$18.50
-0.8%		$18.12
$11.48
▼
$21.89
$826.67M0.7510,145 shs389,529 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$89.98
+3.4%		$80.14
$60.10
▼
$156.00
$3.11B1.9698,421 shs542,597 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-1.79%+6.14%+30.96%+90.11%+48.17%
AxoGen, Inc. stock logo
AXGN
AxoGen
+2.51%-6.20%+6.77%+12.80%+209.29%
SiBone stock logo
SIBN
SiBone
-0.75%-3.70%+2.55%+22.35%+14.06%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+3.45%+1.75%+17.64%+29.60%-15.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.75
Moderate Buy$52.000.93% Upside
AxoGen, Inc. stock logo
AXGN
AxoGen
2.75
Moderate Buy$51.566.78% Upside
SiBone stock logo
SIBN
SiBone
2.71
Moderate Buy$24.1730.63% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.38
Hold$124.1838.01% Upside

Current Analyst Ratings Breakdown

Latest SIBN, TMDX, AXGN, and ATRC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$45.00 ➝ $64.00
8/31/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/27/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$50.00 ➝ $60.00
8/26/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/26/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$60.00
8/24/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/24/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$45.00 ➝ $55.00
8/20/2026
SiBone stock logo
SIBN
SiBone
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/19/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D+) ➝ Hold (C-)
8/5/2026
SiBone stock logo
SIBN
SiBone
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/5/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$80.00 ➝ $77.00
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M4.90$0.31 per share167.61$10.15 per share5.08
AxoGen, Inc. stock logo
AXGN
AxoGen
$225.21M11.52N/AN/A$4.77 per share10.12
SiBone stock logo
SIBN
SiBone
$213.60M3.84N/AN/A$4.11 per share4.50
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$668.47M4.65$4.06 per share22.15$14.99 per share6.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.21245.35114.49N/A1.85%2.34%1.77%11/4/2026 (Estimated)
AxoGen, Inc. stock logo
AXGN
AxoGen
-$15.70M-$0.68N/A965.60N/A-13.36%-8.90%-6.47%11/4/2026 (Estimated)
SiBone stock logo
SIBN
SiBone
-$18.90M-$0.34N/AN/AN/A-6.85%-8.23%-6.07%11/9/2026 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$3.8923.1339.81N/A22.69%15.88%5.95%11/4/2026 (Estimated)

Latest SIBN, TMDX, AXGN, and ATRC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.4955$0.44-$0.0555$0.41$184.00 million$189.95 million
8/3/2026Q2 2026
SiBone stock logo
SIBN
SiBone
-$0.1495-$0.09+$0.0595-$0.09$55.34 million$56.01 million
7/29/2026Q2 2026
AxoGen, Inc. stock logo
AXGN
AxoGen
$0.1214$0.12-$0.0014-$0.03$67.10 million$69.73 million
7/23/2026Q2 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0017$0.18+$0.1817$0.18$151.80 million$153.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.14
4.22
3.19
AxoGen, Inc. stock logo
AXGN
AxoGen
0.07
6.60
5.04
SiBone stock logo
SIBN
SiBone
0.20
9.15
7.55
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.62
6.62
6.07

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
SiBone stock logo
SIBN
SiBone
98.11%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
AxoGen, Inc. stock logo
AXGN
AxoGen
2.44%
SiBone stock logo
SIBN
SiBone
4.00%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,30050.87 million48.83 millionOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45053.76 million52.45 millionOptionable
SiBone stock logo
SIBN
SiBone
35044.35 million42.58 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.56 million32.18 millionOptionable

Recent News About These Companies

TransMedics Group, Inc. $TMDX Position Increased by Wellington Management Group LLP
September 5 at 4:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-transmedics-group-inc-tmdx-position-increased-by-wellington-management-group-llp-2026-09-05/
The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX
September 5 at 4:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-acquires-shares-of-17159-transmedics-group-inc-tmdx-2026-09-05/
TransMedics Group, Inc. $TMDX Position Increased by FirstWave Capital Management LLC
September 5 at 4:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-transmedics-group-inc-tmdx-position-increased-by-firstwave-capital-management-llc-2026-09-05/
19,289 Shares in TransMedics Group, Inc. $TMDX Bought by Corient Private Wealth LP
September 5 at 3:44 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-19289-shares-in-transmedics-group-inc-tmdx-bought-by-corient-private-wealth-lp-2026-09-05/
Legal & General Group Plc Invests $5.29 Million in TransMedics Group, Inc. $TMDX
September 4 at 4:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-legal-general-group-plc-invests-529-million-in-transmedics-group-inc-tmdx-2026-09-04/
TransMedics Group, Inc. $TMDX Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
September 4 at 4:48 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-transmedics-group-inc-tmdx-shares-sold-by-ubs-am-a-distinct-business-unit-of-ubs-asset-management-americas-llc-2026-09-04/
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
September 3 at 3:00 PM  |  zacks.comhttps://www.zacks.com/stock/news/2984745/is-tmdx-stock-worth-buying-as-growth-meets-rising-margin-pressure?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2984745
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?
September 3 at 12:36 PM  |  zacks.comhttps://www.zacks.com/stock/news/2984530/why-is-transmedics-tmdx-up-10-2-since-last-earnings-report?cid=cs-stocknewsapi-ft-realtime_blog-2984530
Braidwell LP Has $40.50 Million Position in TransMedics Group, Inc. $TMDX
September 3 at 4:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-braidwell-lp-has-4050-million-position-in-transmedics-group-inc-tmdx-2026-09-03/
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
September 2 at 10:10 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355615/673/en/transmedics-group-inc-investor-news-rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-transmedics-group-inc-tmdx.html
Empowered Funds LLC Purchases New Stake in TransMedics Group, Inc. $TMDX
September 2 at 3:52 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-empowered-funds-llc-purchases-new-stake-in-transmedics-group-inc-tmdx-2026-09-02/
193,752 Shares in TransMedics Group, Inc. $TMDX Purchased by Bank of New York Mellon Corp
September 2 at 3:14 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-193752-shares-in-transmedics-group-inc-tmdx-purchased-by-bank-of-new-york-mellon-corp-2026-09-02/
Headlands Technologies LLC Purchases Shares of 24,599 TransMedics Group, Inc. $TMDX
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-headlands-technologies-llc-purchases-shares-of-24599-transmedics-group-inc-tmdx-2026-09-01/
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
August 31, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-transmedics-group-inc--tmdx-302865499.html
TransMedics to Present at Upcoming September Investor Conferences
August 31, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-september-investor-conferences-302865120.html
TransMedics Group (NASDAQ:TMDX) Trading Down 5.5% - Time to Sell?
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-trading-down-55-time-to-sell-2026-08-31/
TransMedics Group, Inc. $TMDX Shares Sold by Beaconlight Capital LLC
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-transmedics-group-inc-tmdx-shares-sold-by-beaconlight-capital-llc-2026-08-31/
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
August 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/29/3352939/673/en/transmedics-group-inc-investor-news-rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-transmedics-group-inc-tmdx.html
Algert Global LLC Purchases 31,710 Shares of TransMedics Group, Inc. $TMDX
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-algert-global-llc-purchases-31710-shares-of-transmedics-group-inc-tmdx-2026-08-29/
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and NeoGenomics (NEO)
August 26, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/4023892/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-and-neogenomics-neo/
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
August 25, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-transmedics-group-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302859280.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$51.52 -0.94 (-1.79%)
As of 09/4/2026 04:00 PM Eastern

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AxoGen stock logo

AxoGen NASDAQ:AXGN

$48.28 +1.18 (+2.51%)
As of 09/4/2026 04:00 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

SiBone stock logo

SiBone NASDAQ:SIBN

$18.50 -0.14 (-0.75%)
As of 09/4/2026 04:00 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$89.98 +3.00 (+3.45%)
As of 09/4/2026 04:00 PM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas